Biologics Product Market Report – 2025 Outlook, Trends, Share, Size & Forecast
MarkNtel Advisors has unveiled its latest research report on the Biologics Market, providing an in-depth analysis of market dynamics, growth prospects, and competitive landscape. This report serves as a valuable resource for stakeholders aiming to capitalize on emerging opportunities and navigate potential challenges in the Biologics industry.
Biologics Market Size: 2025 Outlook
The Global Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030. The surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the industry growth. Other factors driving the demand for biologics across the global scale include enhanced usage of monoclonal antibodies for disease treatment, innovation & advancement in the healthcare & biotechnology sectors, and to cure diseases, including anemia, rheumatoid arthritis, osteoporosis, Alzheimer's, etc. Also, diseases like cancer and autoimmune disorders, which pose significant healthcare challenges, underscore the importance of targeted therapeutic interventions, and hence, have been driving the need for biologics over the historical years.
U.S. tariffs are changing—are you prepared? Download your free sample PDF of the report for timely data and expert advice – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html
? Scope of the Report
- Forecasts till 2030 with year-wise market breakdown
- Geographical and segment-level analysis
- Company profiles and strategic insights
- Key market drivers and restraints
- Analysis of market trends and investment opportunities
What’s Driving the Market?
Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products..
Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/global-biologics-market.html
Use your official business email to connect with our team and enjoy full access with priority support.
Biologics Market Segmentation
By Therapeutic Application
- Oncology- Market Size & Forecast 2020-2030, (USD Million)
- Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
- Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
- Diabetes- Market Size & Forecast 2020-2030, (USD Million)
- Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
- Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)
By Drug Class
- Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
- Hormones- Market Size & Forecast 2020-2030, (USD Million)
- Cytokines- Market Size & Forecast 2020-2030, (USD Million)
- Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
- Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
- Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
- Vaccines- Market Size & Forecast 2020-2030, (USD Million)
- Others- Market Size & Forecast 2020-2030, (USD Million)
By Source
- Microbes- Market Size & Forecast 2020-2030, (USD Million)
- Humans- Market Size & Forecast 2020-2030, (USD Million)
- Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
? Industry Leaders: Who’s Dominating the Biologics Market?
The market is highly competitive, with players launching innovation-driven products and investing in strategic partnerships. Key participants include:
- Business Description
- Pfizer
- Sanofi
- Janssen Biotech, Inc.
- Bayer AG
- Merck & Co.
- Amgen Inc.
- Abbott GmbH
- Novartis
- AstraZeneca Plc
- GlaxoSmithKline Biologicals
- Moderna, Inc.
- Ferring Pharmaceuticals Inc.
- Aimmune Therapeutics, Inc.
- Hoffman La Rochey.
These companies are focused on health-based R&D, expansion, and functional ingredient diversification.
Looking for Global, Regional or country-specific reports on this market?
Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support - https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html
? Frequently Asked Questions (FAQs)
- What are the main drivers of the Biologics market?
- Which segment leads the Biologics industry?
- What regulatory challenges impact product development?
- Who are the top players in the Biologics industry?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us:
MarkNtel Advisors LLP
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
For Sales Enquiries: sales@marknteladvisors.com
